BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12642866)

  • 1. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell.
    Zeisig BB; García-Cuéllar MP; Winkler TH; Slany RK
    Oncogene; 2003 Mar; 22(11):1629-37. PubMed ID: 12642866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion gene.
    Ninomiya M; Abe A; Yokozawa T; Ozeki K; Yamamoto K; Ito M; Ito M; Kiyoi H; Emi N; Naoe T
    Cancer Genet Cytogenet; 2006 Aug; 169(1):1-11. PubMed ID: 16875930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
    Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
    Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
    Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
    Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLL-ENL cooperates with SCF to transform primary avian multipotent cells.
    Schulte CE; von Lindern M; Steinlein P; Beug H; Wiedemann LM
    EMBO J; 2002 Aug; 21(16):4297-306. PubMed ID: 12169632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy.
    Chen W; Li Q; Hudson WA; Kumar A; Kirchhof N; Kersey JH
    Blood; 2006 Jul; 108(2):669-77. PubMed ID: 16551973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
    Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
    Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the initiation and progression of human acute leukemia in mice.
    Barabé F; Kennedy JA; Hope KJ; Dick JE
    Science; 2007 Apr; 316(5824):600-4. PubMed ID: 17463288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein.
    Liu H; Chen B; Xiong H; Huang QH; Zhang QH; Wang ZG; Li BL; Chen Z; Chen SJ
    Oncogene; 2004 Apr; 23(19):3385-94. PubMed ID: 15077184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells.
    Pession A; Martino V; Tonelli R; Beltramini C; Locatelli F; Biserni G; Franzoni M; Freccero F; Montemurro L; Pattacini L; Paolucci G
    Oncogene; 2003 Nov; 22(54):8671-6. PubMed ID: 14647461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
    Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis of myeloid and lymphoid lineage markers during mouse haematopoiesis.
    Sakhinia E; Byers R; Bashein A; Hoyland J; Buckle AM; Brady G
    Br J Haematol; 2006 Oct; 135(1):105-16. PubMed ID: 16925795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids.
    Igarashi H; Medina KL; Yokota T; Rossi MI; Sakaguchi N; Comp PC; Kincade PW
    Int Immunol; 2005 May; 17(5):501-11. PubMed ID: 15746243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
    Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
    Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vitro maturation of hematopoietic stem cells from wild-type and immunoglobulin transgenic mice.
    Jayne JA; Reid S; Braun SE; Broxmeyer HE
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):195-204. PubMed ID: 10850382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.